These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Caspofungin for invasive candidiasis at a tertiary care medical center. Zaas AK, Dodds Ashley ES, Alexander BD, Johnson MD, Perfect JR. Am J Med; 2006 Nov; 119(11):993.e1-6. PubMed ID: 17071169 [Abstract] [Full Text] [Related]
23. Caspofungin for the treatment of candidaemia in patients with haematological malignancies. Pagano L, Fianchi L, Fanci R, Candoni A, Caira M, Posteraro B, Morselli M, Valentini CG, Farina G, Mitra ME, Offidani M, Sanguinetti M, Tosti ME, Nosari A, Leone G, Viale P. Clin Microbiol Infect; 2010 Mar; 16(3):298-301. PubMed ID: 19549221 [Abstract] [Full Text] [Related]
39. Candida krusei--a serious complication in patients with hematological malignancies: successful treatment with caspofungin. Conen A, Weisser M, Jörg CO, Battegay M, Trampuz A, Frei R, Christen S, Heim D, Gratwohl A, Flückiger U. Transpl Infect Dis; 2008 Feb; 10(1):66-70. PubMed ID: 17511816 [Abstract] [Full Text] [Related]
40. Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis. Maertens J, Glasmacher A, Herbrecht R, Thiebaut A, Cordonnier C, Segal BH, Killar J, Taylor A, Kartsonis N, Patterson TF, Aoun M, Caillot D, Sable C, Caspofungin Combination Therapy Study Group. Cancer; 2006 Dec 15; 107(12):2888-97. PubMed ID: 17103444 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]